These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 92104)
61. [Laboratory indices of the activity of the sympatho-adrenal system in healthy persons]. Bol'shakova TD; Gugutishvili TsG; Zutler AS; Kiseleva ZM; Kolesov DV Lab Delo; 1969; 6():323-6. PubMed ID: 4185828 [No Abstract] [Full Text] [Related]
62. [Effect of various hypotensive agents on urinary excretion of catecholamines and vanilmandelic acid]. Woyda J; Gryglewska I Pol Tyg Lek; 1973 Jul; 28(30):1141-4. PubMed ID: 4732709 [No Abstract] [Full Text] [Related]
63. [Sympathetic nervous system activity and beta receptor blockers in sports]. Aigner A Wien Med Wochenschr; 1979 Sep; 129(15):411-4. PubMed ID: 92104 [No Abstract] [Full Text] [Related]
65. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension. Pedersen EB Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641 [No Abstract] [Full Text] [Related]
66. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?]. Lohmann FW Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915 [TBL] [Abstract][Full Text] [Related]
68. The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death. Gillis AM; Clusin WT Compr Ther; 1984 Sep; 10(9):60-7. PubMed ID: 6207977 [No Abstract] [Full Text] [Related]
69. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Podrid PJ; Fuchs T; Candinas R Circulation; 1990 Aug; 82(2 Suppl):I103-13. PubMed ID: 1973640 [TBL] [Abstract][Full Text] [Related]
70. [Anabolic effects of statin and beta-blocker on bone metabolism]. Taguchi M; Takeuchi Y Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180 [TBL] [Abstract][Full Text] [Related]
71. Effects of beta-blockers on fracture risk. Reid IR J Musculoskelet Neuronal Interact; 2008; 8(2):105-10. PubMed ID: 18622079 [TBL] [Abstract][Full Text] [Related]
72. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists. Packer M J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808 [TBL] [Abstract][Full Text] [Related]
73. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system. Packer M Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667 [TBL] [Abstract][Full Text] [Related]
74. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
76. The involvement of the sympathetic nervous system in tetanus. Hörtnagl H; Brücke T; Hackl JM Klin Wochenschr; 1979 Apr; 57(8):383-9. PubMed ID: 37368 [TBL] [Abstract][Full Text] [Related]